Covid-19 Update
Dec 21, 2021

From all of us at Research Capital, we wish you the best and brightest of this holiday season and prosperity and good health in 2022.

With the resurgence of Covid-19 cases and the Omicron variant, we have made the decision to defer our January 4 target date for our staff return to our offices until a future date. The safety of our associates and clients is, and will always be, a top priority.

For Research Capital this means that only certain essential staff will be working from our office premises and we will once again have to ask visitors to refrain from physically coming to the office during this time. While we are prepared to continue working from home, it's certainly not what we had been hoping for.

Restrictions and guidelines vary between provinces and regions. Since the beginning of the pandemic Research Capital continues to operate and conduct business almost as usual. The office towers which house our Head Office and most of our branches continue to require physical distancing and mask protocols in elevators and within our office space and limit the number of employees who can be present. Our cage operations continue to receive and deliver securities and funds electronically and by mail and courier. Our trading operations continue to operate as usual.

Volatility in the securities markets has resumed in reaction to the prospect of the economic impact of the new surge of Covid-19. While some may see that as a risk, volatility is an important part of markets and may afford investment opportunities. Now is a great time to connect with your Research Capital advisor.

We will update this message as changes occur. In the meantime, we will continue to provide the highest level of service and look forward to brighter days in 2022. Stay safe.

Geoff Whitlam
President